Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development.

Estrogen receptor (ER)-negative breast cancer is thought to be more malignant and devastating than ER-positive breast cancer and exhibit elevated NF-κB activity. How abnormally high NF-κB activity is maintained in ER-negative breast cancer is poorly understood. The importance of linear ubiquitination, which is generated by the linear ubiquitin chain assembly complex (LUBAC), is increasingly appreciated in NF-κB signaling, which regulates cell activation and death. Here, we showed that epsin proteins, a family of ubiquitin-binding endocytic adaptors, interacted with LUBAC via its Ubiquitin-Interacting Motif (UIM) and bound LUBAC's bona fide substrate NEMO via its N-terminal homolog (ENTH) domain. Furthermore, epsins promoted NF-κB essential modulator (NEMO) linear ubiquitination and served as scaffolds for recruiting other components of the IκB kinase (IKK) complex; thereby, resulting in the heightened IKK activation and sustained NF-κB signaling essential for the development of ER-negative breast cancer. Heightened epsin levels in ER-negative human breast cancer are associated with poor, relapse-free survival. We showed that transgenic and pharmacological approaches eliminating epsins potently impeded breast cancer development in both spontaneous and patient-derived xenograft breast cancer mouse models. Our findings established the pivotal role epsins played in promoting breast cancer. Thus, targeting epsins may represent a strategy to restrain NF-κB signaling, and provide an important perspective into ER-negative breast cancer treatment.

[1]  N. Tanner,et al.  Remodeling Membrane Binding by Mono-Ubiquitylation , 2019, Biomolecules.

[2]  Hao Wu,et al.  Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes , 2018, The Journal of clinical investigation.

[3]  R. Ghiasvand,et al.  Expression of the three components of linear ubiquitin assembly complex in breast cancer , 2018, PloS one.

[4]  J. Bertin,et al.  LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis , 2018, Nature.

[5]  M. Gyrd-Hansen,et al.  The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation. , 2017, Molecular cell.

[6]  D. Vučić,et al.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling , 2017, Cell Death and Differentiation.

[7]  Karin Dahlman-Wright,et al.  AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression. , 2016, The Journal of Biological Chemistry.

[8]  Lois E. H. Smith,et al.  Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis. , 2016, Circulation research.

[9]  Hao Wu,et al.  Motif mimetic of epsin perturbs tumor growth and metastasis. , 2015, The Journal of clinical investigation.

[10]  C. Pudney,et al.  Polyubiquitin Drives the Molecular Interactions of the NF-κB Essential Modulator (NEMO) by Allosteric Regulation , 2015, The Journal of Biological Chemistry.

[11]  Hao Wu,et al.  Epsin is required for Dishevelled stability and Wnt signaling activation in colon cancer development , 2015, Nature Communications.

[12]  Hao Wu,et al.  Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function , 2014, Science Signaling.

[13]  J. Martinez-Barbera,et al.  HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. , 2014, Cell reports.

[14]  Xin-Yun Huang,et al.  A Signal Transducer and Activator of Transcription 3·Nuclear Factor κB (Stat3·NFκB) Complex Is Necessary for the Expression of Fascin in Metastatic Breast Cancer Cells in Response to Interleukin (IL)-6 and Tumor Necrosis Factor (TNF)-α* , 2014, The Journal of Biological Chemistry.

[15]  R. Adams,et al.  Genetic Reduction of Vascular Endothelial Growth Factor Receptor 2 Rescues Aberrant Angiogenesis Caused by Epsin Deficiency , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[16]  K. Iwai,et al.  Mechanism Underlying IκB Kinase Activation Mediated by the Linear Ubiquitin Chain Assembly Complex , 2014, Molecular and Cellular Biology.

[17]  Patrick G. A. Pedrioli,et al.  Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains , 2013, Proceedings of the National Academy of Sciences.

[18]  Mark B. Jones,et al.  Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitination. , 2013, Cell reports.

[19]  Yunzhou Dong,et al.  Endocytic Adaptor Protein Epsin Is Elevated in Prostate Cancer and Required for Cancer Progression , 2013, ISRN oncology.

[20]  Samir J. Courdy,et al.  Patient‐Derived Models of Human Breast Cancer: Protocols for In Vitro and In Vivo Applications in Tumor Biology and Translational Medicine , 2013, Current protocols in pharmacology.

[21]  P. De Camilli,et al.  Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. , 2012, The Journal of clinical investigation.

[22]  A. Krešo,et al.  Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer , 2012, Oncogene.

[23]  Mark T. W. Ebbert,et al.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.

[24]  K. Rajewsky,et al.  Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. , 2011, The Journal of clinical investigation.

[25]  Anthony W. Purcell,et al.  Linear ubiquitination prevents inflammation and regulates immune signalling , 2011, Nature.

[26]  Y. Saeki,et al.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex , 2011, Nature.

[27]  J. Kutok,et al.  Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. , 2010, Cancer cell.

[28]  P. De Camilli,et al.  Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi , 2010, Proceedings of the National Academy of Sciences.

[29]  J. Camonis,et al.  The Epsin Family of Endocytic Adaptors Promotes Fibrosarcoma Migration and Invasion* , 2010, The Journal of Biological Chemistry.

[30]  H. Habelhah.  Emerging complexity of protein ubiquitination in the NF-κB pathway. , 2010, Genes & cancer.

[31]  Annie P. Moseman,et al.  IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-κB p50 , 2010, Proceedings of the National Academy of Sciences.

[32]  Christoph H Emmerich,et al.  Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. , 2009, Molecular cell.

[33]  P. De Camilli,et al.  Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both epsin 1 and epsin 2 in mice , 2009, Proceedings of the National Academy of Sciences.

[34]  Zuoren Yu,et al.  Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. , 2009, The American journal of pathology.

[35]  Nobuhiro Suzuki,et al.  Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation , 2009, Cell.

[36]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[37]  W. Schneider-Brachert,et al.  Regulation of TNFR1 and CD95 signalling by receptor compartmentalization , 2008, Nature Reviews Molecular Cell Biology.

[38]  Vrajesh V. Parekh,et al.  Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo1 , 2008, The Journal of Immunology.

[39]  David L. Smith,et al.  Signal processing by its coil zipper domain activates IKKγ , 2008, Proceedings of the National Academy of Sciences.

[40]  G. Courtois,et al.  Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. , 2007, Human molecular genetics.

[41]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[42]  Zhijian J. Chen.  Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[43]  P. De Camilli,et al.  The association of epsin with ubiquitinated cargo along the endocytic pathway is negatively regulated by its interaction with clathrin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[45]  D. Kabelitz,et al.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.

[46]  Andreas Sommer,et al.  NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression , 2004 .

[47]  Debajit K. Biswas,et al.  NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis , 2004 .

[48]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[49]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[50]  B. Wendland.  Epsins: adaptors in endocytosis? , 2002, Nature Reviews Molecular Cell Biology.

[51]  S. Ghosh,et al.  Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.

[52]  R. Mohney,et al.  The Ubiquitin-Interacting Motifs Target the Endocytic Adaptor Protein Epsin for Ubiquitination , 2002, Current Biology.

[53]  Pier Paolo Di Fiore,et al.  A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins , 2002, Nature.

[54]  A. Pardee,et al.  The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Lohi,et al.  Epsin 3 Is a Novel Extracellular Matrix-induced Transcript Specific to Wounded Epithelia* , 2001, The Journal of Biological Chemistry.

[56]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[57]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[58]  Pier Paolo Di Fiore,et al.  Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis , 1998, Nature.

[59]  L. Hennighausen,et al.  Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.

[60]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[61]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.